178 related articles for article (PubMed ID: 25299931)
1. Dynamic contrast-enhanced MRI for differentiation of major salivary glands neoplasms, a 3-T MRI study.
Aghaghazvini L; Salahshour F; Yazdani N; Sharifian H; Kooraki S; Pakravan M; Shakiba M
Dentomaxillofac Radiol; 2015; 44(2):20140166. PubMed ID: 25299931
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of dynamic contrast-enhanced MRI in the salivary gland tumors.
Hisatomi M; Asaumi J; Yanagi Y; Unetsubo T; Maki Y; Murakami J; Matsuzaki H; Honda Y; Konouchi H
Oral Oncol; 2007 Oct; 43(9):940-7. PubMed ID: 17257881
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of dynamic-enhanced MRI in salivary gland tumors: retrospective study and literature review.
Ogawa T; Kojima I; Ishii R; Sakamoto M; Murata T; Suzuki T; Kato K; Nakanome A; Ohkoshi A; Ishida E; Kakehata S; Shiga K; Katori Y
Eur Arch Otorhinolaryngol; 2018 Jun; 275(6):1613-1621. PubMed ID: 29623392
[TBL] [Abstract][Full Text] [Related]
4. Value of dynamic contrast enhanced MRI in differential diagnostics of Warthin tumors and parotid malignancies.
Mikaszewski B; Markiet K; Smugała A; Stodulski D; Garsta E; Piątkowski J; Szurowska E
Sci Rep; 2021 Aug; 11(1):16282. PubMed ID: 34381113
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic efficacy of diffusion-weighted imaging and semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging in salivary gland tumors.
Gökçe E; Beyhan M
World J Radiol; 2023 Jan; 15(1):20-31. PubMed ID: 36721673
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of various salivary gland tumours using diffusion-weighted MRI and dynamic contrast-enhanced MRI.
Kushwaha M; Kumar J; Garg A; Singh I; Khurana N
Pol J Radiol; 2023; 88():e203-e215. PubMed ID: 37234459
[TBL] [Abstract][Full Text] [Related]
7. Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation.
Yabuuchi H; Fukuya T; Tajima T; Hachitanda Y; Tomita K; Koga M
Radiology; 2003 Feb; 226(2):345-54. PubMed ID: 12563124
[TBL] [Abstract][Full Text] [Related]
8. Differentiating benign and malignant salivary gland tumours: diagnostic criteria and the accuracy of dynamic contrast-enhanced MRI with high temporal resolution.
Lam PD; Kuribayashi A; Imaizumi A; Sakamoto J; Sumi Y; Yoshino N; Kurabayashi T
Br J Radiol; 2015 May; 88(1049):20140685. PubMed ID: 25791568
[TBL] [Abstract][Full Text] [Related]
9. Warthin tumor of the parotid gland: diagnostic value of MR imaging with histopathologic correlation.
Ikeda M; Motoori K; Hanazawa T; Nagai Y; Yamamoto S; Ueda T; Funatsu H; Ito H
AJNR Am J Neuroradiol; 2004 Aug; 25(7):1256-62. PubMed ID: 15313720
[TBL] [Abstract][Full Text] [Related]
10. Minor salivary gland tumors in the oral cavity: diagnostic value of dynamic contrast-enhanced MRI.
Matsuzaki H; Yanagi Y; Hara M; Katase N; Asaumi J; Hisatomi M; Unetsubo T; Konouchi H; Takenobu T; Nagatsuka H
Eur J Radiol; 2012 Oct; 81(10):2684-91. PubMed ID: 22138118
[TBL] [Abstract][Full Text] [Related]
11. Incidental finding of upper lip Warthin tumor.
Petrocelli M; Sbordone C; Salzano G; Orabona GD; Cassandro FM; Fusetti S; Califano L; Cassandro E
Ann Ital Chir; 2017 Nov; 6():. PubMed ID: 29134953
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of dynamic magnetic resonance imaging for salivary gland diseases: a preliminary study.
Suenaga S; Indo H; Noikura T
Dentomaxillofac Radiol; 2001 Nov; 30(6):314-8. PubMed ID: 11641729
[TBL] [Abstract][Full Text] [Related]
13. [The value of dynamic contrast-enhanced MRI in the differentiation between benign and malignant lacrimal epithelial tumors].
Wang YZ; Xian JF; Wang XY; Guo J; Song LY
Zhonghua Yi Xue Za Zhi; 2023 Aug; 103(31):2427-2432. PubMed ID: 37599217
[No Abstract] [Full Text] [Related]
14. The diagnostic value of combining conventional, diffusion-weighted imaging and dynamic contrast-enhanced MRI for salivary gland tumors.
Zheng N; Li R; Liu W; Shao S; Jiang S
Br J Radiol; 2018 Sep; 91(1089):20170707. PubMed ID: 29902075
[TBL] [Abstract][Full Text] [Related]
15. Imaging biomarkers in the diagnosis of salivary gland tumors: the value of lesion/parenchyma ratio of perfusion-MR pharmacokinetic parameters.
Mungai F; Verrone GB; Bonasera L; Bicci E; Pietragalla M; Nardi C; Berti V; Mazzoni LN; Miele V
Radiol Med; 2021 Oct; 126(10):1345-1355. PubMed ID: 34181206
[TBL] [Abstract][Full Text] [Related]
16. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of malignant from benign orbital masses.
Yuan Y; Kuai XP; Chen XS; Tao XF
Eur J Radiol; 2013 Sep; 82(9):1506-11. PubMed ID: 23561057
[TBL] [Abstract][Full Text] [Related]
17. Salivary gland tumors at in vivo proton MR spectroscopy.
King AD; Yeung DK; Ahuja AT; Tse GM; Yuen HY; Wong KT; van Hasselt AC
Radiology; 2005 Nov; 237(2):563-9. PubMed ID: 16244265
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of salivary gland tumours using diffusion-weighted image-based virtual MR elastography: a pilot study.
Jung HN; Ryoo I; Suh S; Kim B; You SH; Kim E
Dentomaxillofac Radiol; 2024 Apr; 53(4):248-256. PubMed ID: 38502962
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging for Differentiation Between Parotid Neoplasms.
Elmokadem AH; Abdel Khalek AM; Abdel Wahab RM; Tharwat N; Gaballa GM; Elata MA; Amer T
Can Assoc Radiol J; 2019 Aug; 70(3):264-272. PubMed ID: 30922790
[TBL] [Abstract][Full Text] [Related]
20. The role of diffusion-weighted and dynamic contrast enhancement perfusion-weighted imaging in the evaluation of salivary glands neoplasms.
Pietragalla M; Nardi C; Bonasera L; Mungai F; Taverna C; Novelli L; De Renzis AGD; Calistri L; Tomei M; Occhipinti M; Colagrande S
Radiol Med; 2020 Sep; 125(9):851-863. PubMed ID: 32266692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
